Comprehensive analysis of SLC43A2 on the tumor immune microenvironment and prognosis of liver hepatocellular carcinoma

Comprehensive analysis of SLC43A2 on the tumor immune microenvironment and prognosis of liver hepatocellular carcinoma

Background: Tumor cells outcompete T cells for methionine via overexpressing SLC43A2, causing T cells exhaustion. We explored the influence of SLC43A2 on tumor immune microenvironment (TIME), immune-related genes (IRGs) and the prognosis of liver hepatocellular carcinoma (LIHC) patients.Methods: The...

Full description

Bibliographic Details
Main Authors:	Yan Liao, Junmei Weng, Lian Chen, Nan Hu, Xun Yuan, Jianhua Wang, Feng He, Yixin Cai, Qin Huang, Jianing Wang, Liu Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Genetics
Subjects:	liver hepatocellular carcinoma (LIHC) SLC43A2 tumor immune microenvironment (TIME) prognostic risk score model prognostic biomarker therapeutic target
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.911378/full

Similar Items

Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma
by: Keqiang Ma, et al.
Published: (2023-01-01)

Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma
by: Xinyi Chen, et al.
Published: (2023-05-01)

Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma
by: Jun Tang, et al.
Published: (2024-01-01)

A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
by: Baohui Zhang, et al.
Published: (2020-09-01)

Tumor purity–associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment
by: Yan Zhao, et al.
Published: (2023-06-01)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
by: Wei Wei, et al.
Published: (2022-07-01)

Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis
by: Xiudan Han, et al.
Published: (2022-10-01)

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
by: Zhen Zhang, et al.
Published: (2022-07-01)

Prediction of novel miRNA biomarker candidates for diagnostic and prognostic analysis of STAD and LIHC: An integrated in silico approach
by: Kumkum Kar, et al.
Published: (2021-01-01)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
by: Yuanxin Shi, et al.
Published: (2023-05-01)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
by: Yuan Yang, et al.
Published: (2021-06-01)

Comprehensive analysis of immune-related prognostic genes in the tumour microenvironment of hepatocellular carcinoma
by: Weike Gao, et al.
Published: (2021-03-01)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
by: Cong Chen, et al.
Published: (2022-06-01)

Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance
by: Wenbiao Chen, et al.
Published: (2020-09-01)

Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer
by: Sun X, et al.
Published: (2023-08-01)

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer
by: Yuhang Wang, et al.
Published: (2023-01-01)

Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma
by: Huili Ren, et al.
Published: (2022-07-01)

Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma
by: Liang Sun, et al.
Published: (2023-06-01)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
by: Hongfei Zhu, et al.
Published: (2022-09-01)

KIF5A upregulation in hepatocellular carcinoma: A novel prognostic biomarker associated with unique tumor microenvironment status
by: Qi Liu, et al.
Published: (2023-01-01)

Editorial: The role of tumor microenvironment in primary liver cancer therapeutic resistance
by: Zhangya Pu, et al.
Published: (2022-07-01)

Identification of hub genes within the CCL18 signaling pathway in hepatocellular carcinoma through bioinformatics analysis
by: Jinlei Mao, et al.
Published: (2024-03-01)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
by: Xingyu Peng, et al.
Published: (2022-09-01)

Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
by: Yingting Xu, et al.
Published: (2023-10-01)

An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma
by: Zhonghai Du, et al.
Published: (2024-04-01)

Identification and validation of functional roles for three MYC-associated genes in hepatocellular carcinoma
by: Sha Li, et al.
Published: (2023-12-01)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
by: Gen Li, et al.
Published: (2022-12-01)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
by: Kinoshita Akiyoshi, et al.
Published: (2013-02-01)

Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
by: Zhijian Wang, et al.
Published: (2023-08-01)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
by: Junyu Huo, et al.
Published: (2021-11-01)

ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC
by: Lingyi Zhou, et al.
Published: (2022-05-01)

A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma
by: Ruiqi Liu, et al.
Published: (2023-03-01)

Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma
by: Zhaochen Liu, et al.
Published: (2022-12-01)

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response
by: Yun-Long Ma, et al.
Published: (2023-02-01)

Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma
by: Lei Pu, et al.
Published: (2024-02-01)

Clinical Diagnostic and Prognostic Potential of NDRG1 and NDRG2 in Hepatocellular Carcinoma Patients
by: Shaohua Xu, et al.
Published: (2022-06-01)

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
by: Yu-Jie Xu, et al.
Published: (2021-11-01)

Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies
by: Erbao Chen, et al.
Published: (2024-04-01)

Construction of an M2 macrophage-related prognostic model in hepatocellular carcinoma
by: Huangqin Song, et al.
Published: (2023-06-01)

STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment
by: Zhangya Pu, et al.
Published: (2022-10-01)